Clinical Trials
4 trialsNCT03755791 2025-12-11
COSMIC-312
Exelixis
Phase 3 Active not recruiting
NCT00576056 2017-02-15
Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC
University of Pittsburgh
Phase 2 Terminated
NCT00941863 2016-03-22
Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)
Bayer
Phase 1 Completed
NCT00863746 2015-01-19
MISSION
Bayer
Phase 3 Completed